Prognostic value of survival in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors: Value of SUVmax or value of other factor?
SUVmax was not associated with survival status. OS was higher in age < 70 years old and in patients with adverse events. PFS was higher in age < 70 years old and in female patients.
Authors
- Taylor J.K
- Lam Le (ORCID: https://orcid.org/0009-0001-1634-3978)
- Hanh-Thao Vo-Thi
- Quy Nguyen (ORCID: https://orcid.org/0000-0002-7016-1155)
- Ba D. Nguyen (ORCID: https://orcid.org/0000-0002-9223-2081)
- Cẩm Phương Phạm (ORCID: https://orcid.org/0000-0002-4342-0959)
- Thi-Bich-Huyen Bui
- T Pham-Van
Institutions
- Hanoi Medical University (VN)
- Bạch Mai Hospital (VN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-08
- DOI
- https://doi.org/10.7417/ct.2025.5165
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00